Aubrun F, Monsel S, Langeron O, Coriat P, Riou B
Department of Anaesthesiology and Critical Care, Centre Hospitalier Universitaire Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.
Eur J Anaesthesiol. 2001 Mar;18(3):159-65. doi: 10.1046/j.0265-0215.2000.00796.x.
Intravenous morphine titration is used to obtain postoperative pain relief, but few studies have assessed the appropriate regimen. In a quality programme, we performed a prospective non-randomized study of morphine titration in a postanaesthesia care unit (PACU).
Four regimens of morphine titration were studied: every 10 (group 1, n = 400) or 5 min (group 2, n = 400) with a maximum of five intravenous boluses; every 5 min, without any limitation in the number of boluses (groups 3 and 4, n = 400 each); in groups 1, 2, and 3, subcutaneous morphine was administered 4 h after titration. In group 4, administration of subcutaneous morphine was allowed only 2 h after titration. A visual analogue pain scale (VAPS) > 30 mm was required to administer morphine and pain relief was defined as a VAPS < or = 30 mm.
After morphine titration, VAPS was lower and the number of patients with pain relief was greater in patients from groups 3 and 4. Patients from group 4 had the lowest VAPS (26 +/- 17 mm) and the highest percentage of pain relief (73%) at the end of the PACU period. The number of sedated patients increased in groups 3 (62%) and 4 (61%) compared with group 1 (27%). No significant differences in morphine-related adverse effects were observed.
Intravenous morphine titration every 5 min with an unlimited number of boluses and early subcutaneous administration provided the best analgesic regimen.
静脉注射吗啡滴定法用于术后疼痛缓解,但很少有研究评估合适的方案。在一项质量改进项目中,我们在麻醉后护理单元(PACU)对吗啡滴定法进行了前瞻性非随机研究。
研究了四种吗啡滴定方案:每10分钟(第1组,n = 400)或5分钟(第2组,n = 400)一次,最大静脉推注5次;每5分钟一次,推注次数无限制(第3组和第4组,每组n = 400);在第1、2和3组中,滴定4小时后给予皮下注射吗啡。在第4组中,仅在滴定2小时后允许给予皮下注射吗啡。视觉模拟疼痛量表(VAPS)> 30 mm时需注射吗啡,疼痛缓解定义为VAPS≤30 mm。
吗啡滴定后,第3组和第4组患者的VAPS较低,疼痛缓解的患者数量较多。在PACU期末,第4组患者的VAPS最低(26±17 mm),疼痛缓解百分比最高(73%)。与第1组(27%)相比,第3组(62%)和第4组(61%)镇静患者数量增加。未观察到吗啡相关不良反应的显著差异。
每5分钟静脉注射吗啡滴定,推注次数无限制,并早期皮下给药提供了最佳镇痛方案。